{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:19:59Z","timestamp":1787555999586,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00292-026-01583-6","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:35:53Z","timestamp":1785274553000},"page":"360-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heredit\u00e4res Leiomyomatose-und-Nierenzellkarzinom-Syndrom","Hereditary leiomyomatosis and renal cell carcinoma syndrome"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0315-1229","authenticated-orcid":false,"given":"Ramona","family":"Erber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"1583_CR1","series-title":"WHO classification of tumours series","volume-title":"Female genital tumours","author":"R Erber","year":"2020","unstructured":"Erber\u00a0R, Weigelt\u00a0B, Garg\u00a0K et\u00a0al (2020) Hereditary leiomyomatosis and renal cell carcinoma. In: WHO Classification of Tumours Editorial Board (Hrsg) Female genital tumours, 5.\u00a0Aufl. WHO classification of tumours series, Bd vol. 4. International Agency for Research on Cancer, Lyon (France)","edition":"5"},{"key":"1583_CR2","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/hmg\/ddg148","volume":"12","author":"NA Alam","year":"2003","unstructured":"Alam\u00a0NA, Rowan\u00a0AJ, Wortham\u00a0NC et\u00a0al (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12:1241\u20131252. https:\/\/doi.org\/10.1093\/hmg\/ddg148","journal-title":"Hum Mol Genet"},{"key":"1583_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03017-z","volume":"19","author":"AB S\u00e1nchez-Heras","year":"2024","unstructured":"S\u00e1nchez-Heras\u00a0AB, D\u00e1maso\u00a0E, Castillejo\u00a0A et\u00a0al (2024) Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome. Orphanet J Rare Dis 19:26. https:\/\/doi.org\/10.1186\/s13023-024-03017-z","journal-title":"Orphanet J Rare Dis"},{"key":"1583_CR4","series-title":"WHO classification of tumours series","volume-title":"Urinary and male genital tumours","author":"AJ Gill","year":"2022","unstructured":"Gill\u00a0AJ, Merino\u00a0MJ, Chen\u00a0N et\u00a0al (2022) Hereditary leiomyomatosis and renal cell carcinoma syndrome. In: WHO Classification of Tumours Editorial Board (Hrsg) Urinary and male genital tumours, 5.\u00a0Aufl. WHO classification of tumours series, Bd 8. International Agency for Research on Cancer, Lyon (France)","edition":"5"},{"key":"1583_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2340\/0001555553409416","volume":"53","author":"WB Reed","year":"1973","unstructured":"Reed\u00a0WB, Walker\u00a0R, Horowitz\u00a0R (1973) Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol 53:409\u2013416","journal-title":"Acta Derm Venereol"},{"key":"1583_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IP Tomlinson","year":"2002","unstructured":"Tomlinson\u00a0IP, Alam\u00a0NA, Rowan\u00a0AJ et\u00a0al (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406\u2013410. https:\/\/doi.org\/10.1038\/ng849","journal-title":"Nat Genet"},{"key":"1583_CR7","unstructured":"https:\/\/www.omim.org\/entry\/606812, aufgerufen am 9. M\u00e4rz 2026"},{"key":"1583_CR8","unstructured":"Leitlinienprogramm-Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2024) S3-Leitlinie S3-Leitlinie Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms, Langversion 5.0, AWMF-Registernummer 043-017OL. https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/nierenzellkarzinom\/. Zugegriffen: 3. M\u00e4rz 2026"},{"key":"1583_CR9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00428-018-2292-6","volume":"472","author":"L Siegler","year":"2018","unstructured":"Siegler\u00a0L, Erber\u00a0R, Burghaus\u00a0S et\u00a0al (2018) Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening. Virchows Arch 472:789\u2013796. https:\/\/doi.org\/10.1007\/s00428-018-2292-6","journal-title":"Virchows Arch"},{"key":"1583_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17040573","volume":"17","author":"M D\u2019Indinosante","year":"2025","unstructured":"D\u2019Indinosante\u00a0M, Lardino\u00a0S, Bruno\u00a0M et\u00a0al (2025) Implications of Fumarate Hydratase Deficiency (FHD) and Cancer Risk: A Window into the Clinical and Oncological Implications of a Rare Disorder in Gynecology. Cancers 17:573","journal-title":"Cancers"},{"key":"1583_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/pgp.0000000000000918","volume":"42","author":"DB Chapel","year":"2023","unstructured":"Chapel\u00a0DB, Sharma\u00a0A, Maccio\u00a0L et\u00a0al (2023) Fumarate Hydratase and S\u2011(2-Succinyl)-Cysteine Immunohistochemistry Shows Evidence of Fumarate Hydratase Deficiency in 2\u202f% of Uterine Leiomyosarcomas: A\u00a0Cohort Study of 348 Tumors. Int J Gynecol Pathol 42:120\u2013135. https:\/\/doi.org\/10.1097\/pgp.0000000000000918","journal-title":"Int J Gynecol Pathol"},{"key":"1583_CR12","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","volume":"23","author":"LJ Castro-Vega","year":"2013","unstructured":"Castro-Vega\u00a0LJ, Buffet\u00a0A, De Cubas\u00a0AA et\u00a0al (2013) Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Human Molecular Genetics 23:2440\u20132446. https:\/\/doi.org\/10.1093\/hmg\/ddt639","journal-title":"Human Molecular Genetics"},{"key":"1583_CR13","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1210\/jc.2006-0183","volume":"91","author":"LG Carvajal-Carmona","year":"2006","unstructured":"Carvajal-Carmona\u00a0LG, Alam\u00a0NA, Pollard\u00a0PJ et\u00a0al (2006) Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations. J\u00a0Clin Endocrinol Metab 91:3071\u20133075. https:\/\/doi.org\/10.1210\/jc.2006-0183","journal-title":"J Clin Endocrinol Metab"},{"key":"1583_CR14","unstructured":"https:\/\/backend.leitlinien.krebsgesellschaft.de\/leitlinien\/s3-leitlinie-diagnostik-therapie-und-nachsorge-des-nierenzellkarzinoms\/private\/ressourcen\/c70t56xssqwp\/@@download\/file, aufgerufen am 4. M\u00e4rz 2026"},{"key":"1583_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","volume":"79","author":"DL Smit","year":"2011","unstructured":"Smit\u00a0DL, Mensenkamp\u00a0AR, Badeloe\u00a0S et\u00a0al (2011) Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet 79:49\u201359. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01486.x","journal-title":"Clin Genet"},{"key":"1583_CR16","volume-title":"GeneReviews(\u00ae)","author":"J Kamihara","year":"1993","unstructured":"Kamihara\u00a0J, Schultz\u00a0KA, Rana\u00a0HQ (1993) FH Tumor Predisposition Syndrome. In: Adam\u00a0MP, Bick\u00a0S, Mirzaa\u00a0GM et\u00a0al (Hrsg) GeneReviews(\u00ae). University of Washington, Seattle, Seattle (WA)"},{"key":"1583_CR17","series-title":"WHO classification of tumours series","volume-title":"Skin tumours","author":"AL Folpe","year":"2023","unstructured":"Folpe\u00a0AL, Fullen\u00a0DR (2023) Cutaneous leiomyomas. In: WHO Classification of Tumours Editorial Board (Hrsg) Skin tumours, 5.\u00a0Aufl. WHO classification of tumours series, Bd vol. 12. International Agency for Research on Cancer, Lyon (France)","edition":"5"},{"key":"1583_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00428-025-04111-8","volume":"487","author":"B Xie","year":"2025","unstructured":"Xie\u00a0B, Li\u00a0Q, Ma\u00a0Q et\u00a0al (2025) Clinicopathological and molecular features of so-called low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma: a study of 5 cases. Virchows Arch 487:377\u2013388. https:\/\/doi.org\/10.1007\/s00428-025-04111-8","journal-title":"Virchows Arch"},{"key":"1583_CR19","unstructured":"https:\/\/hlrccalliance.org\/, aufgerufen am 4. M\u00e4rz 2026"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-026-01583-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-026-01583-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-026-01583-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:28:18Z","timestamp":1787552898000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-026-01583-6"}},"subtitle":["Pathologische Merkmale, Diagnostik und klinische Implikationen","Pathological features, diagnostics, and clinical implications"],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1583"],"URL":"https:\/\/doi.org\/10.1007\/s00292-026-01583-6","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"value":"2731-7188","type":"print"},{"value":"2731-7196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.\u00a0Erber ist Koautorin der WHO Classification of Tumours: Female Genital Tumours (International Agency for Research on Cancer, Lyon, 2020). A.\u00a0Hartmann ist mandatierter Vertreter der Deutschen Gesellschaft f\u00fcr Pathologie (DGP), der Arbeitsgemeinschaft Onkologische Pathologie (AOP) in der Deutschen Krebsgesellschaft (DKG) sowie des Bundesverbands Deutscher Pathologen (BDP) f\u00fcr die S3-Leitlinie \u201eDiagnostik, Therapie und Nachsorge des Nierenzellkarzinoms\u201c. Dar\u00fcber hinaus war er als Expert Member an der Erstellung der WHO Classification of Tumours: Urinary and Male Genital Tumours (International Agency for Research on Cancer, Lyon, 2022) beteiligt. R.\u00a0Erber und A.\u00a0Hartmann geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}